+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Intrapartum Monitoring Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 184 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5890053
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare leaders seeking to advance maternal and fetal care face challenges in driving clinical excellence, elevating patient safety, and ensuring cost efficiency. The intrapartum monitoring devices market delivers targeted solutions that support executive priorities while aligning technology adoption with operational and compliance goals.

Market Snapshot: Intrapartum Monitoring Devices Market

The intrapartum monitoring devices market reached a value of USD 1.85 billion in 2024, with projections pointing to USD 1.98 billion in 2025 and USD 3.18 billion by 2032. This reflects a compound annual growth rate (CAGR) of 6.94%. Market growth is driven by the uptake of real-time monitoring technologies and evolving care delivery models in perinatal environments. Healthcare organizations are focusing on devices that integrate seamlessly with existing workflows, support improved clinical documentation, and enhance interoperability across systems. Senior management and procurement leaders are increasingly guiding purchasing strategies toward solutions that deliver reliability, ongoing regulatory compliance, and scalability. Key manufacturers are responding by optimizing device capabilities and reinforcing adaptability to new guidelines.

Scope & Segmentation of the Intrapartum Monitoring Devices Market

  • Technology: Non-invasive cardiotocography systems and Doppler ultrasonography offer continuous monitoring, while internal methods—like fetal scalp electrodes and intrauterine pressure catheters—provide detailed insights for complex or high-acuity cases.
  • Application: Devices support use across hospitals, maternity clinics, ambulatory surgical settings, and home care environments, empowering protocol standardization and remote patient assessment.
  • End User: Adoption spans private and public hospitals as well as home healthcare providers, each needing uninterrupted monitoring, efficient data exchange, and coordinated care transitions between care settings.
  • Device Type: Offerings include contraction monitors (such as tocodynamometers and intrauterine catheters) and fetal monitoring solutions (for example, Doppler devices, cardiotocography systems, and fetal ECGs), providing comprehensive data for labor and delivery teams.
  • Distribution Channel: Procurement is conducted through centralized purchasing hubs, specialist distributors, digital marketplaces, and retail channels, supporting consistent device access across varied provider networks.
  • Geography: North America and Europe benefit from developed perinatal care systems and advanced technology infrastructure, while Asia-Pacific, the Middle East, and Africa are experiencing increased adoption, improved care standards, and emerging expansion opportunities.
  • Key Companies: Major participants—such as General Electric Company, Koninklijke Philips N.V., Baxter International Inc., Drägerwerk AG & Co. KGaA, Medtronic plc, NIHON KOHDEN CORPORATION, Natus Medical Incorporated, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Edan Instruments, Inc., and Huntleigh Healthcare Limited—lead advancements in technology and streamline supply chains.

Key Takeaways for Senior Decision-Makers

  • Implementing modern intrapartum monitoring platforms enhances rapid assessment of maternal and fetal status, reinforcing alignment with established protocols and supporting safer delivery outcomes across care settings.
  • Integrating monitoring devices with electronic health records optimizes workflow efficiency, minimizes documentation errors, and promotes stronger care team collaboration, meeting current regulatory expectations.
  • Wireless and portable monitoring technology expands patient mobility and enables providers to manage spatial constraints and dynamic staffing in high-volume clinical units.
  • Supporting a modular device approach allows organizations to incrementally upgrade equipment, maintain continuity of operations, and adapt to emerging clinical requirements with minimal disruption.
  • Strategic collaborations with manufacturers empower healthcare institutions to tailor device selection, adjust protocols to organizational needs, and remain responsive to updated compliance standards.
  • Diversified procurement models and resilient supply logistics help maintain device reliability and operational consistency as external regulations and market conditions shift.

Tariff Impact on Supply Chains and Cost Structure

Recent adjustments in U.S. tariff policy have prompted manufacturers to rethink sourcing and distribution strategies. For healthcare organizations, timely adaptation is critical to contain costs, secure device availability, and comply with global regulations—ensuring continuity in perinatal care within a changing regulatory environment.

Methodology & Data Sources

This report leverages structured interviews with clinical, procurement, and executive stakeholders, supplemented by extensive secondary research and reviews of up-to-date regulatory information. This methodology delivers relevant, practical perspectives on current challenges and opportunities in the intrapartum monitoring devices market.

Why This Report Matters for Senior Leaders

  • Obtain actionable insights to guide strategic investments and strengthen risk management within perinatal and fetal care operations.
  • Gain clarity on the impact of ongoing supply chain and regulatory changes for both immediate procurement efforts and longer-term technology planning in diverse healthcare markets.
  • Apply practical recommendations to reinforce supply stability and build effective partnerships, optimizing maternal and fetal monitoring across the care continuum.

Conclusion

Senior decision-makers are equipped to enhance procurement strategies, maintain high clinical standards, and respond effectively as the intrapartum monitoring devices market evolves. Leveraging these insights supports resilience and excellence across dynamic care environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Real-time AI-powered predictive analytics for fetal distress detection during labor
5.2. Wireless wearable maternal and fetal monitoring patch enabling continuous labor assessment in home settings
5.3. Integration of remote telehealth platforms with intrapartum monitoring devices for virtual labor management
5.4. Non-invasive uterine activity monitoring using advanced sensor fusion for enhanced contraction detection accuracy
5.5. Development of low-cost portable intrapartum monitoring systems for resource-limited and emerging healthcare markets
5.6. Novel thin-film electrochemical fetal ECG electrodes reducing signal interference and improving monitoring clarity
5.7. Cloud-based Internet of Medical Things solutions aggregating labor data for real-time clinical decision support dashboards
5.8. Patient-centric mobile applications integrating maternal feedback and biometric data from intrapartum monitoring devices
5.9. Minimally invasive fetal scalp monitoring catheters with biocompatible coatings reducing infection risk during high-risk deliveries
5.10. Hybrid cephalopelvic monitoring combining ultrasound and tocodynamometry for comprehensive intrapartum assessment accuracy
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Intrapartum Monitoring Devices Market, by Technology
8.1. External Monitoring
8.1.1. Cardiotocography
8.1.2. Doppler Ultrasonography
8.2. Internal Monitoring
8.2.1. Fetal Scalp Electrode
8.2.2. Intrauterine Pressure Catheter
9. Intrapartum Monitoring Devices Market, by Application
9.1. Continuous Monitoring
9.1.1. Fixed Systems
9.1.2. Wireless Systems
9.2. Intermittent Monitoring
9.2.1. Handheld Doppler
9.2.2. Portable Monitors
10. Intrapartum Monitoring Devices Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Home Healthcare
10.3. Hospitals
10.3.1. Private Hospital
10.3.2. Public Hospital
10.4. Maternity Centers
11. Intrapartum Monitoring Devices Market, by Device Type
11.1. Contraction Monitoring Device
11.1.1. External Tocodynamometer
11.1.2. Intrauterine Pressure Catheter
11.2. Fetal Monitoring Device
11.2.1. Cardiotocography Monitors
11.2.2. Doppler Fetal Monitors
11.2.3. Fetal ECG Monitors
12. Intrapartum Monitoring Devices Market, by Distribution Channel
12.1. Hospital Purchase
12.2. Online Sales
12.3. Retail Sales
12.4. Third-Party Distributors
13. Intrapartum Monitoring Devices Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Intrapartum Monitoring Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Intrapartum Monitoring Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. General Electric Company
16.3.2. Koninklijke Philips N.V.
16.3.3. Baxter International Inc.
16.3.4. Drägerwerk AG & Co. KGaA
16.3.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.3.6. Medtronic plc
16.3.7. NIHON KOHDEN CORPORATION
16.3.8. Natus Medical Incorporated
16.3.9. Edan Instruments, Inc.
16.3.10. Huntleigh Healthcare Limited

Companies Mentioned

The companies profiled in this Intrapartum Monitoring Devices market report include:
  • General Electric Company
  • Koninklijke Philips N.V.
  • Baxter International Inc.
  • Drägerwerk AG & Co. KGaA
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Medtronic plc
  • NIHON KOHDEN CORPORATION
  • Natus Medical Incorporated
  • Edan Instruments, Inc.
  • Huntleigh Healthcare Limited

Table Information